Diagnostic Accuracy Study of Intraoperative and Perioperative Serum Intact PTH Level for Successful Parathyroidectomy in 501 Secondary Hyperparathyroidism Patients
- PMID: 27231027
- PMCID: PMC4882599
- DOI: 10.1038/srep26841
Diagnostic Accuracy Study of Intraoperative and Perioperative Serum Intact PTH Level for Successful Parathyroidectomy in 501 Secondary Hyperparathyroidism Patients
Abstract
Parathyroidectomy (PTX) is an effective treatment for severe secondary hyperparathyroidism (SHPT); however, persistent SHPT may occur because of supernumerary and ectopic parathyroids. Here a diagnostic accuracy study of intraoperative and perioperative serum intact parathyroid hormone (iPTH) was performed to predict successful surgery in 501 patients, who received total PTX + autotransplantation without thymectomy. Serum iPTH values before incision (io-iPTH0), 10 and 20 min after removing the last parathyroid (io-iPTH10, io-iPTH20), and the first and fourth day after PTX (D1-iPTH, D4-iPTH) were recoded. Patients whose serum iPTH was >50 pg/mL at the first postoperative week were followed up within six months. Successful PTX was defined if iPTH was <300 pg/mL, on the contrary, persistent SHPT was regarded. There were 86.4% patients underwent successful PTX, 9.8% remained as persistent SHPT and 3.8% were undetermined. Intraoperative serum iPTH demonstrated no significant differences in two subgroups with or without chronic hepatitis. Receiver operating characteristic (ROC) curves showed that >88.9% of io-iPTH20% could predict successful PTX (area under the curve [AUC] 0.909, sensitivity 78.6%, specificity 88.5%), thereby avoiding unnecessary exploration to reduce operative complications. D4-iPTH >147.4 pg/mL could predict persistent SHPT (AUC 0.998, sensitivity 100%, specificity 99.5%), so that medical intervention or reoperation start timely.
Figures
Similar articles
-
Diagnostic Values of Intraoperative (1-84) Parathyroid Hormone Levels are Superior to Intact Parathyroid Hormone for Successful Parathyroidectomy in Patients With Chronic Kidney Disease.Endocr Pract. 2021 Nov;27(11):1065-1071. doi: 10.1016/j.eprac.2021.04.006. Epub 2021 Apr 22. Endocr Pract. 2021. PMID: 33895317
-
Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol.World J Surg. 2006 May;30(5):743-51. doi: 10.1007/s00268-005-0379-0. World J Surg. 2006. PMID: 16680589
-
A Retrospective Study of the Impact of Intraoperative Intact Parathyroid Hormone Monitoring During Total Parathyroidectomy for Secondary Hyperparathyroidism: STARD Study.Medicine (Baltimore). 2015 Jul;94(29):e1213. doi: 10.1097/MD.0000000000001213. Medicine (Baltimore). 2015. PMID: 26200645 Free PMC article.
-
Treatment for secondary hyperparathyroidism focusing on parathyroidectomy.Front Endocrinol (Lausanne). 2023 Apr 20;14:1169793. doi: 10.3389/fendo.2023.1169793. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37152972 Free PMC article. Review.
-
Surgical management of secondary hyperparathyroidism: how to effectively reduce recurrence at the time of primary surgery.J Endocrinol Invest. 2016 May;39(5):509-14. doi: 10.1007/s40618-015-0410-8. Epub 2015 Nov 30. J Endocrinol Invest. 2016. PMID: 26620950 Review.
Cited by
-
Endoscopic parathyroidectomy versus open parathyroidectomy for patients with refractory secondary hyperparathyroidism: a meta-analysis.Wideochir Inne Tech Maloinwazyjne. 2023 Dec;18(4):578-587. doi: 10.5114/wiitm.2023.132439. Epub 2023 Oct 27. Wideochir Inne Tech Maloinwazyjne. 2023. PMID: 38239584 Free PMC article.
-
Prognostic analysis and risk assessment based on RNA editing in hepatocellular carcinoma.J Appl Genet. 2024 Jan 13. doi: 10.1007/s13353-023-00819-y. Online ahead of print. J Appl Genet. 2024. PMID: 38217666
-
Maximal parathyroid gland diameter as a predictive factor for autograft-dependent recurrent secondary hyperparathyroidism after total parathyroidectomy.Front Endocrinol (Lausanne). 2023 Jun 15;14:1175237. doi: 10.3389/fendo.2023.1175237. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37396185 Free PMC article.
-
18F-Fluorocholine PET/CT Compared with Current Imaging Procedures for Preoperative Localization of Hyperfunctioning Parathyroids in Patients with Chronic Kidney Disease.Diagnostics (Basel). 2023 Apr 8;13(8):1374. doi: 10.3390/diagnostics13081374. Diagnostics (Basel). 2023. PMID: 37189475 Free PMC article.
-
Relationships between blood bone metabolic biomarkers and anemia in patients with chronic kidney disease.Ren Fail. 2023 Dec;45(1):2210227. doi: 10.1080/0886022X.2023.2210227. Ren Fail. 2023. PMID: 37170583 Free PMC article.
References
-
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney international. Supplement, S1–130, 10.1038/ki.2009.188 (2009). - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
